Key facts
| Company | City Market, Inc. |
|---|---|
| FDA office | Human Foods Program |
| Letter date | May 15, 2026 |
| Subject / product | Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions |
| CFR citations | FDA Warning Letter |
| Response due | 15 working days from receipt (standard FDA warning-letter requirement) |
| Reference / source ID | city-market-inc-727003-05152026 |
What happens next
City Market, Inc. is expected to respond to FDA in writing, typically within 15 working days of the letter date, describing the specific corrective and preventive actions taken or planned for each violation cited. FDA reviews that response and any follow-up evidence, and can conduct a re-inspection to confirm the corrections were actually made. If FDA judges the response inadequate, or the underlying conditions serious enough, further action can follow, including product seizure, injunction, import alert, or civil penalties; many Warning Letters are resolved through corrective action alone. This page reflects the Warning Letter as issued and will not reflect any subsequent correction unless FDA publishes a follow-up record. FDA issues Warning Letters after an inspection or other review when it believes a firm has significantly violated FDA regulations; the letter itself is a notice, not a final adjudication.
Violations explained
FDA Warning Letter — Violations FDA cited at City Market, Inc.
WARNING LETTER City Market, Inc. MARCS-CMS 727003 — May 15, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA ELECTRONIC DELIVERY Product: Food & Beverages Recipient: Recipient Name Frank H. Owens Jr. Recipient Title Owner City Market, Inc. 1508 Gloucester Street Brunswick , GA 31520-7143 United States frankowensjr76@gmail.com Issuing Office: Human Foods Program United States May 15, 2026 WARNING LETTER Re: CMS #727003 Dear Mr. Owens: The United States Food and Drug Administration (FDA) conducted an inspection of your seafood processing facility located at 1508 Gloucester Street, Brunswick, GA 31520, from January 7, 2026, through January 9, 2026. During our inspection, the FDA investigator found serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation, Title 21, Code of Federal Regulations, Part 123. Based on FDA’s inspectional findings we have determined that your ready-to-eat pasteurized canned crab meat is adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. § 342(a)(4)) in that they have been prepared, packed, or held under insanitary conditions whereby they may have been rendered injurious to health. Furthermore, in accordance with 21 CFR 123.6(g), failure of a processor of fish or fishery products to have and implement a HACCP plan that complies with 21 CFR 123.6 whenever a HACCP plan is necessary or otherwise operate in accordance with the requirements of Part 123, renders the fish or fishery products adulterated within the meaning of section 402(a)(4) of the Act, 21 U.S.C. § 342(a)(4). You may find the Act, the seafood HACCP regulation, and the June 2022 Edition of the Fish and Fisheries Products Hazards and Controls Guidance (the Hazards Guide) through links in FDA's home page at www.fda.gov. At the conclusion of the inspection, the FDA investigator issued your facility a Form FDA 483 (FDA-483), Inspectional Observations, listing the deviations found at your firm. To date, we have not received a response to the FDA-483 issued to you on January 9, 2026. We are issuing this letter to advise you of FDA’s concerns and to provide detailed information describing the findings at your facility. Your significant violations of the seafood HACCP regulation are as follows: 1. You did not implement the monitoring procedures listed in your HACCP plan for the receiving and storage of pasteurized canned crab meat to control the hazard of Clostridium botulinum (C. botulinum) growth and toxin formation to comply with 21 CFR 123.6(b). During receiving, your firm did not implement the listed monitoring procedure of using a temperature monitoring device for the finished product temperature during shipping. During storage, your firm did not implement the listed monitoring procedure of visually observing the quantity of ice. Your firm did not have monitoring records for the receiving and storage of pasteurized canned crab meat. Additionally, on January 7, 2026, pasteurized canned crab meat that was received by your firm in December of 2025, was stored in your cooler without ice while other cans were stored with ice, but not with a sufficient amount of ice to completely surround each can. Furthermore, the thermometer located inside the cooler measured the ambient air temperature to be approximately (b)(4) °F at the beginning of the inspection and after three hours approximately (b)(4) °F. Pasteurized canned crab meat is thermally processed to control non-proteolytic C. botulinum and should be held at 40°F to control proteolytic C. botulinum . When temperatures are between 50°F and 70°F, the maximum cumulative exposure time limit to control proteolytic C. botulinum is 11 hours. After 11 hours, the product is considered to be unsafe due to potential formation of botulinum toxin, the deadliest known toxin. 2. You must have a HACCP plan that at a minimum lists the critical limits that must be met
City Market, Inc.’s FDA history
Argus HQ has recorded 1 total FDA action tied to City Market, Inc.: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
Full letter text
Read the rest of the full text
Frequently asked questions
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- What is an FDA Warning Letter?
- An FDA Warning Letter notifies a company that FDA believes it has significantly violated FDA regulations and that prompt corrective action is required. It is issued after an inspection, sample analysis, or other FDA review, and is a notice -- not a final legal determination and not itself a penalty.
- Does this Warning Letter mean City Market, Inc. violated the law?
- FDA's letter documents violations it believes it found at City Market, Inc.. A Warning Letter is not a final adjudication of guilt; the company has an opportunity to respond and correct the cited issues, and many Warning Letters are resolved without further enforcement once FDA confirms adequate correction.
- What happens after a Warning Letter is issued?
- The firm generally must respond in writing within 15 working days; FDA reviews the response and can escalate to seizure, injunction, or import alert if it judges the response inadequate. Many Warning Letters are resolved through corrective action alone.
Get the next warning letter in this therapeutic area before your team hears about it secondhand.
Weekly briefing, free. Upgrade any time for daily or real-time delivery.
Related enforcement actions
Full FDA history for City Market, Inc.- Warning letter (recent): Med Shop Inc / www.medshopinc.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): ketaminetroches.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketdaxandrugs / www.ketdaxandrugs.org — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Legit Ketamine Suppliers / www.legitketaminesuppliers.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketamine Store / www.ketaminestore.org — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Buy Keta Online / www.buyketaonline.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketamine Troche Store / www.ketaminetrochestore.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): All Ketamine HCL / www.allketaminehcl.com — Unapproved New Drugs/Misbranded (2026-06-23) →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Warning Letter to City Market, Inc. (May 15, 2026) — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions. Digital Empire LLC. Retrieved from https://argushq.ai/warning-letter/city-market-727003-2026-05-15
"FDA Warning Letter to City Market, Inc. (May 15, 2026) — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/warning-letter/city-market-727003-2026-05-15.
Argus HQ Research. "FDA Warning Letter to City Market, Inc. (May 15, 2026) — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/warning-letter/city-market-727003-2026-05-15.
@misc{argushq_argushq_ai_warning_letter_city_market_727003_2026_05_15_2026,
title = {FDA Warning Letter to City Market, Inc. (May 15, 2026) — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/warning-letter/city-market-727003-2026-05-15},
note = {Accessed: July 13, 2026}
}Source: FDA.gov — Warning Letters ↗

